{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T13:50:25Z","timestamp":1791985825690,"version":"4.4.0"},"reference-count":17,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,3,12]],"date-time":"2024-03-12T00:00:00Z","timestamp":1710201600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100019347","name":"Tistou and Charlotte Kerstan Stiftung","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100019347","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["ophthalmologyscience.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Ophthalmology Science"],"published-print":{"date-parts":[[2024,9]]},"DOI":"10.1016\/j.xops.2024.100516","type":"journal-article","created":{"date-parts":[[2024,3,15]],"date-time":"2024-03-15T04:47:18Z","timestamp":1710478038000},"page":"100516","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"title":["Dose-Dependent Progression of Chorioretinal Atrophy at the Injection Site After Subretinal Injection of rAAV2\/8 in Nonhuman Primates"],"prefix":"10.1016","volume":"4","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3086-6425","authenticated-orcid":false,"given":"Immanuel P.","family":"Seitz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabian","family":"Wozar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3490-4588","authenticated-orcid":false,"given":"G. Alex","family":"Ochakovski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Felix F.","family":"Reichel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Faik","family":"Gelisken","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K. Ulrich","family":"Bartz-Schmidt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tobias","family":"Peters","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7459-1024","authenticated-orcid":false,"given":"M. Dominik","family":"Fischer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.xops.2024.100516_bib1","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1136\/bjophthalmol-2021-321023","article-title":"Development of retinal atrophy after subretinal gene therapy with voretigene neparvovec","volume":"107","author":"Reichel","year":"2023","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.xops.2024.100516_bib2","doi-asserted-by":"crossref","first-page":"e55","DOI":"10.1097\/IAE.0000000000003576","article-title":"Retinal pigment epithelium atrophy after subretinal voretigene neparvovec-rzyl for RPE65-related disease: a 6-month follow-up","volume":"42","author":"Giansanti","year":"2022","journal-title":"Retina"},{"key":"10.1016\/j.xops.2024.100516_bib3","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.oret.2021.03.016","article-title":"Perifoveal chorioretinal atrophy after subretinal voretigene neparvovec-rzyl for RPE65-mediated leber congenital amaurosis","volume":"6","author":"Gange","year":"2022","journal-title":"Ophthalmol Retina"},{"key":"10.1016\/j.xops.2024.100516_bib4","doi-asserted-by":"crossref","DOI":"10.1016\/j.preteyeres.2020.100915","article-title":"Immune responses to retinal gene therapy using adeno-associated viral vectors - implications for treatment success and safety","volume":"83","author":"Bucher","year":"2021","journal-title":"Prog Retin Eye Res"},{"key":"10.1016\/j.xops.2024.100516_bib5","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1016\/j.ophtha.2022.06.018","article-title":"Inflammation after voretigene neparvovec administration in patients with RPE65-related retinal dystrophy","volume":"129","author":"Kessel","year":"2022","journal-title":"Ophthalmology"},{"key":"10.1016\/j.xops.2024.100516_bib6","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1167\/tvst.10.6.15","article-title":"Longitudinal evaluation of hyper-reflective foci in the retina following subretinal delivery of adeno-associated virus in non-human primates","volume":"10","author":"Rodr\u00edguez-Bocanegra","year":"2021","journal-title":"Transl Vis Sci Technol"},{"key":"10.1016\/j.xops.2024.100516_bib7","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-022-17269-x","article-title":"Plasmid-mediated gene transfer of Cas9 induces vector-related but not SpCas9-related immune responses in human retinal pigment epithelial cells","volume":"12","author":"Pfromm","year":"2022","journal-title":"Sci Rep"},{"key":"10.1016\/j.xops.2024.100516_bib8","doi-asserted-by":"crossref","first-page":"2648","DOI":"10.1016\/j.ymthe.2017.08.018","article-title":"AAV8 can induce innate and adaptive immune response in the primate eye","volume":"25","author":"Reichel","year":"2017","journal-title":"Mol Ther"},{"key":"10.1016\/j.xops.2024.100516_bib9","doi-asserted-by":"crossref","first-page":"1887","DOI":"10.1056\/NEJMoa1414221","article-title":"Long-term effect of gene therapy on leber's congenital amaurosis","volume":"372","author":"Bainbridge","year":"2015","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.xops.2024.100516_bib10","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1016\/j.ophtha.2023.02.015","article-title":"Full-field scotopic threshold improvement after voretigene neparvovec-rzyl treatment correlates with chorioretinal atrophy","volume":"130","author":"Stingl","year":"2023","journal-title":"Ophthalmology"},{"key":"10.1016\/j.xops.2024.100516_bib11","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1016\/j.ophtha.2019.06.017","article-title":"Efficacy, safety, and durability of voretigene neparvovec-rzyl in RPE65 mutation-associated inherited retinal dystrophy: results of phase 1 and 3 trials","volume":"126","author":"Maguire","year":"2019","journal-title":"Ophthalmology"},{"key":"10.1016\/j.xops.2024.100516_bib12","doi-asserted-by":"crossref","first-page":"1890","DOI":"10.1038\/s41598-023-28830-7","article-title":"Extra-viral DNA in adeno-associated viral vector preparations induces TLR9-dependent innate immune responses in human plasmacytoid dendritic cells","volume":"13","author":"Bucher","year":"2023","journal-title":"Sci Rep"},{"key":"10.1016\/j.xops.2024.100516_bib13","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1001\/archophthalmol.2011.295","article-title":"Functional and anatomic consequences of subretinal dosing in the cynomolgus macaque","volume":"130","author":"Nork","year":"2012","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.xops.2024.100516_bib14","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0209996","article-title":"The influence of subretinal injection pressure on the microstructure of the monkey retina","volume":"13","author":"Takahashi","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.xops.2024.100516_bib15","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1002\/sctm.18-0210","article-title":"Optimizing donor cellular dissociation and subretinal injection parameters for stem cell-based treatments","volume":"8","author":"Scruggs","year":"2019","journal-title":"Stem Cells Transl Med"},{"key":"10.1016\/j.xops.2024.100516_bib16","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1159\/000522110","article-title":"Controlled subretinal injection pressure prevents damage in pigs","volume":"245","author":"Olufsen","year":"2022","journal-title":"Ophthalmologica"},{"key":"10.1016\/j.xops.2024.100516_bib17","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1089\/hgtb.2016.086","article-title":"Evaluation of an optimized injection system for retinal gene therapy in human patients","volume":"27","author":"Fischer","year":"2016","journal-title":"Hum Gene Ther Methods"}],"container-title":["Ophthalmology Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666914524000526?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666914524000526?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,9,18]],"date-time":"2024-09-18T23:56:56Z","timestamp":1726703816000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666914524000526"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9]]},"references-count":17,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2024,9]]}},"alternative-id":["S2666914524000526"],"URL":"https:\/\/doi.org\/10.1016\/j.xops.2024.100516","relation":{},"ISSN":["2666-9145"],"issn-type":[{"value":"2666-9145","type":"print"}],"subject":[],"published":{"date-parts":[[2024,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Dose-Dependent Progression of Chorioretinal Atrophy at the Injection Site After Subretinal Injection of rAAV2\/8 in Nonhuman Primates","name":"articletitle","label":"Article Title"},{"value":"Ophthalmology Science","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.xops.2024.100516","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Published by Elsevier Inc. on behalf of the American Academy of Ophthalmology.","name":"copyright","label":"Copyright"}],"article-number":"100516"}}